These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 9154322)

  • 1. Receptor specificity and trigemino-vascular inhibitory actions of a novel 5-HT1B/1D receptor partial agonist, 311C90 (zolmitriptan).
    Martin GR; Robertson AD; MacLennan SJ; Prentice DJ; Barrett VJ; Buckingham J; Honey AC; Giles H; Moncada S
    Br J Pharmacol; 1997 May; 121(2):157-64. PubMed ID: 9154322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-clinical pharmacology of zolmitriptan (Zomig; formerly 311C90), a centrally and peripherally acting 5HT1B/1D agonist for migraine.
    Martin GR
    Cephalalgia; 1997 Oct; 17 Suppl 18():4-14. PubMed ID: 9399012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of 5-HT(1B/1D) and 5-HT2A receptors in 5-HT-induced contraction of endothelium-denuded rabbit epicardial coronary arteries.
    Ellwood AJ; Curtis MJ
    Br J Pharmacol; 1997 Nov; 122(5):875-84. PubMed ID: 9384503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterisation of 5-HT receptors in human coronary arteries by molecular and pharmacological techniques.
    Nilsson T; Longmore J; Shaw D; Pantev E; Bard JA; Branchek T; Edvinsson L
    Eur J Pharmacol; 1999 May; 372(1):49-56. PubMed ID: 10374714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. F 11356, a novel 5-hydroxytryptamine (5-HT) derivative with potent, selective, and unique high intrinsic activity at 5-HT1B/1D receptors in models relevant to migraine.
    John GW; Pauwels PJ; Perez M; Halazy S; Le Grand B; Verscheure Y; Valentin JP; Palmier C; Wurch T; Chopin P; Marien M; Kleven MS; Koek W; Assie MB; Carilla-Durand E; Tarayre JP; Colpaert FC
    J Pharmacol Exp Ther; 1999 Jul; 290(1):83-95. PubMed ID: 10381763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The in vivo pharmacological profile of eletriptan (UK-116,044): a potent and novel 5-HT(1B/1D) receptor agonist.
    Gupta P; Butler P; Shepperson NB; McHarg A
    Eur J Pharmacol; 2000 Jun; 398(1):73-81. PubMed ID: 10856450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the vasoconstrictor effects of the selective 5-HT1D-receptor agonist L-775,606 with the mixed 5-HT1B/1D-receptor agonist sumatriptan and 5-HT in human isolated coronary artery.
    Longmore J; Maguire JJ; MacLeod A; Street L; Schofield WN; Hill RG
    Br J Clin Pharmacol; 2000 Feb; 49(2):126-31. PubMed ID: 10671906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of chronic sumatriptan and zolmitriptan treatment on 5-HT receptor expression and function in rats.
    Reuter U; Salomone S; Ickenstein GW; Waeber C
    Cephalalgia; 2004 May; 24(5):398-407. PubMed ID: 15096229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of trigeminal neurons by intravenous administration of the serotonin (5HT)1B/D receptor agonist zolmitriptan (311C90): are brain stem sites therapeutic target in migraine?
    Goadsby PJ; Hoskin KL
    Pain; 1996 Oct; 67(2-3):355-9. PubMed ID: 8951929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The in vivo pharmacological profile of a 5-HT1 receptor agonist, CP-122,288, a selective inhibitor of neurogenic inflammation.
    Gupta P; Brown D; Butler P; Ellis P; Grayson KL; Land GC; Macor JE; Robson SF; Wythes MJ; Shepperson NB
    Br J Pharmacol; 1995 Nov; 116(5):2385-90. PubMed ID: 8581273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a 5-HT1B receptor on CHO cells: functional responses in the absence of radioligand binding.
    Giles H; Lansdell SJ; Bolofo ML; Wilson HL; Martin GR
    Br J Pharmacol; 1996 Mar; 117(6):1119-26. PubMed ID: 8882605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No contractile effect for 5-HT1D and 5-HT1F receptor agonists in human and bovine cerebral arteries: similarity with human coronary artery.
    Bouchelet I; Case B; Olivier A; Hamel E
    Br J Pharmacol; 2000 Feb; 129(3):501-8. PubMed ID: 10711348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-Hydroxytryptamine(1F) receptors do not participate in vasoconstriction: lack of vasoconstriction to LY344864, a selective serotonin(1F) receptor agonist in rabbit saphenous vein.
    Cohen ML; Schenck K
    J Pharmacol Exp Ther; 1999 Sep; 290(3):935-9. PubMed ID: 10454462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cranial vascular effects of zolmitriptan, a centrally active 5-HT1B/1D receptor partial agonist for the acute treatment of migraine.
    MacLennan SJ; Cambridge D; Whiting MV; Marston C; Martin GR
    Eur J Pharmacol; 1998 Nov; 361(2-3):191-7. PubMed ID: 9865508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterisation of the 5-HT receptor binding profile of eletriptan and kinetics of [3H]eletriptan binding at human 5-HT1B and 5-HT1D receptors.
    Napier C; Stewart M; Melrose H; Hopkins B; McHarg A; Wallis R
    Eur J Pharmacol; 1999 Mar; 368(2-3):259-68. PubMed ID: 10193663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensity dependence of the cortical auditory evoked potentials as a surrogate marker of central nervous system serotonin transmission in man: demonstration of a central effect for the 5HT1B/1D agonist zolmitriptan (311C90, Zomig).
    Proietti-Cecchini A; Afra J; Schoenen J
    Cephalalgia; 1997 Dec; 17(8):849-54; discussion 799. PubMed ID: 9453273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contractile 5-HT1B receptors in human cerebral arteries: pharmacological characterization and localization with immunocytochemistry.
    Nilsson T; Longmore J; Shaw D; Olesen IJ; Edvinsson L
    Br J Pharmacol; 1999 Nov; 128(6):1133-40. PubMed ID: 10578124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SB-649915, a novel, potent 5-HT1A and 5-HT1B autoreceptor antagonist and 5-HT re-uptake inhibitor in native tissue.
    Scott C; Soffin EM; Hill M; Atkinson PJ; Langmead CJ; Wren PB; Faedo S; Gordon LJ; Price GW; Bromidge S; Johnson CN; Hagan JJ; Watson J
    Eur J Pharmacol; 2006 Apr; 536(1-2):54-61. PubMed ID: 16571351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the human basilar artery contractile response to 5-HT and triptans.
    Silva SA; Marques FB; Fontes Ribeiro CA
    Fundam Clin Pharmacol; 2007 Jun; 21(3):265-72. PubMed ID: 17521295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 311C90: increasing the options for therapy with effective acute antimigraine 5HT1B/1D receptor agonists.
    Ferrari MD
    Neurology; 1997 Mar; 48(3 Suppl 3):S21-4. PubMed ID: 9071266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.